AGIO News and Press, Agios Pharmaceuticals Inc.

Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact The Gross Law Firm for Details- AGIO PR Newswire NEW YORK , March 10, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Agios Pharmaceuticals, Inc...

2026-03-09 11:34:33 ET When I last looked at Agios Pharmaceuticals ( AGIO ) in mid-June of last year, I concluded that article noting that Agios had a fortress balance sheet. The stock merited a ' Speculative Buy ' rating for risk-tolerant investors. The shares moved up ...

Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO PR Newswire NEW YORK , March 3, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to share...

PYRUKYND is the only medicine approved in the UAE for adults with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia  NewBridge Pharmaceuticals, a regional specialty company, will continue to manage commercialization of PYRUKYND in the Gulf region CAMBRIDGE,...

2026-02-23 10:57:17 ET On February 17, 2026, Commodore Capital disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold all 2,338,287 shares of Agios Pharmaceuticals (NASDAQ:AGIO) in the fourth quarter, an estimated $93.86 million transaction. According t...

2026-02-17 15:58:22 ET On February 17, 2026, Rock Springs Capital Management LP disclosed in an SEC filing that it sold 159,379 shares of Agios Pharmaceuticals (NASDAQ:AGIO) in the fourth quarter, an estimated $5.59 million transaction based on quarterly average pricing. Accordi...

2026-02-12 17:05:18 ET More on Agios Pharmaceuticals Agios Pharmaceuticals, Inc. (AGIO) Q4 2025 Earnings Call Transcript Agios Pharmaceuticals, Inc. (AGIO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Agios Pharmaceuticals, Inc. (AGIO) Present...

2026-02-12 17:04:21 ET Agios Pharmaceuticals, Inc. (AGIO) Q4 2025 Earnings Call February 12, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Agios Pharmaceuticals, Inc. (AGIO) Q4 2025 Earnings Call Transcript

2026-02-12 11:24:03 ET Image source: The Motley Fool. Thursday, Feb. 12, 2026 at 8:00 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-12 06:33:29 ET More on Agios Pharmaceuticals Agios Pharmaceuticals, Inc. (AGIO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Agios Pharmaceuticals, Inc. (AGIO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Agios...